Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.

Abstract

Sulfasalazine, in doses used for inflammatory bowel disease, appears to be an effective alternative therapy for delayed pressure urticaria and angioedema in patients poorly controlled by traditional treatment and may act as a corticosteroid-sparing agent.